PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...
Hosted on MSN1h
Ukrainian unit innovates to counter Russian drone threatA Ukrainian military unit has developed a method to counter Russian FPV drones controlled via a deployable fibre optic cable.
Hosted on MSN22d
Baltic Sea: Finland finds anchor that severed cablesFinnish police have reported finding the anchor responsible for severing an undersea internet cable connecting Finland to Estonia. Ireland weather: New Status Orange low temperature and ice ...
PGN has evolved from a gas transmission and distribution company into an integrated energy solution provider, connecting Indonesia's natural gas supplies with customers across the country. PGN and its ...
PGN-EDODM1 is under clinical development by Pepgen and currently in Phase I for Myotonic Dystrophy. According to GlobalData, Phase I drugs for Myotonic Dystrophy does not have sufficient historical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback